Waardenburg syndrome

Seminars in Hearing

Volumn 27, Issue 3, 2006, Pages 171-181

  Schultz, Julie M ^a,b  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Dystopia canthorum; Hereditary deafness; PAX3; Pigmentation anomalies; Waardenburg syndrome

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; COCHLEA PROSTHESIS; CONGENITAL DEAFNESS; FAMILIAL DISEASE; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; HEARING AID; HUMAN; NEURAL CREST; PENETRANCE; PERCEPTION DEAFNESS; PHENOTYPE; PIGMENT DISORDER; REVIEW; WAARDENBURG SYNDROME;

EID: 33746630884     PISSN: 07340451     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947284     Document Type: Review

References (70)

1. Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet 1951;3:195-253
2. Arias S. Genetic heterogeneity in the Waardenburg syndrome. Birth Defects Orig Artic Ser 1971; 07:87-101
3. Arias S, Mota M. Apparent non-penetrance for dystopia in Waardenburg syndrome type I, with some hints on the diagnosis of dystopia canthorum. J Genet Hum 1978;26:103-131
4. Farrer LA, Arnos KS, Asher JH Jr, et al. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes. Am J Hum Genet 1994; 55:728-737
5. Hageman MJ, Delleman JW. Heterogeneity in Waardenburg syndrome. Am J Hum Genet 1977; 29:468-485
6. Farrer LA, Grundfast KM, Amos J, et al. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am J Hum Genet 1992;50:902-913
7. Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet 1995;55:95-100
8. Goodman RM, Lewithal I, Solomon A, Klein D. Upper limb involvement in the Klein-Waardenburg syndrome. Am J Med Genet 1982;11:425-433
9. Shah KN, Dalai SJ, Desai MP, Sheth PN, Joshi NC, Ambani LM. White forelock, pigmentary disorder of indes, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome. J Pediatr 1981;99:432-435
10. Fraser GR. The Causes of Profound Deafness in Childhood: a Study of 3,535 Individuals with Severe Hearing Loss Present at Birth or of Childhood Onset. Baltimore, MD: The Johns Hopkins University Press; 1976
11. Partington MW. Waardenburg's syndrome and heterochromia iridum in a deaf school population. Can Med Assoc J 1964;90:1008-1017
12. Sellars S, Beighton P. The Waardenburg syndrome in deaf children in southern Africa. S Afr Med J 1983;63:725-728
13. Newton V. Hearing loss and Waardenburg's syndrome: implications for genetic counselling. J Laryngol Otol 1990;104:97-103
14. Fisch L. Deafness as part of an hereditary syndrome. J Laryngol Otol 1959;73:355-382
15. Hageman MJ. Audiometric findings in 34 patients with Waardenburg's syndrome. J Laryngol Otol 1977;91:575-584
16. Oysu C, Baserer N, Tinaz M. Audiometric manifestations of Waardenburg's syndrome. Ear Nose Throat J 2000;79:704-709
17. Liu XZ, Newton VE. Distortion product emissions in normal-hearing and low-frequency hearing loss carriers of genes for Waardenburg's syndrome. Ann Otol Rhinol Laryngol 1997;106:220-225
18. Lonsbury-Martin BL, Martin GK, Whitehead ML. Distortion-product otoacoustic emissions in the normal hearing population. In: Robinette MS, Glattke TJ, eds. Otoacoustic Emissions: Clinical Applications. New York, NY: Thieme; 1997:83-109
19. Reynolds JE, Meyer JM, Landa B, et al. Analysis of variability of clinical manifestations in Waardenburg syndrome. Am J Med Genet 1995;57:540-547
20. Oysu C, Oysu A, Asian I, Tinaz M. Temporal bone imaging findings in Waardenburg's syndrome. Int J Pediatr Otorhinolaryngol 2001;58:215-221
21. Migirov L, Henkin Y, Hildesheimer M, Muchnik C, Kronenberg J. Cochlear implantation in Waardenburg's syndrome. Acta Otolaryngol 2005;125:713-717
22. Daneshi A, Hassanzadeh S, Farhadi M. Cochlear implantation in children with Waardenburg syndrome. J Laryngol Otol 2005;119:719-723
23. Foy C, Newton V, Wellesley D, Harris R, Read AP. Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the Splotch mouse. Am J Hum Genet 1990;46:1017-1023
24. Asher JH Jr, Morell R, Friedman TB. Waardenburg syndrome (WS): the analysis of a single family with a WS1 mutation showing linkage to RFLP markers on human chromosome 2q. Am J Hum Genet 1991;48:43-52
25. Ishikiriyama S, Tonoki H, Shibuya Y, et al. Waardenburg syndrome type I in a child with de novo inversion (2)(q35q37.3). Am J Med Genet 1989;33:505-507
26. Asher JH Jr, Friedman TB. Mouse and hamster mutants as models for Waardenburg syndromes in humans. J Med Genet 1990;27:618-626
27. Epstein DJ, Vekemans M, Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 1991;67:767-774
28. Tassabehji M, Read AP, Newton VE, et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992;355:635-636
29. Baldwin CT, Hoth CF, Amos JA, da-Silva EO, Milunsky A. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 1992;355:637-638
30. Morell R, Friedman TB, Moeljopawiro S, Hartono, Soewito, Asher JH Jr. A frameshift mutation in the HuP2 paired domain of the probable human homolog of murine Pax-3 is responsible for Waardenburg syndrome type 1 in an Indonesian family. Hum Mol Genet 1992;1:243-247
31. Tassabehji M, Newton VE, Liu XZ, et al. The mutational spectrum in Waardenburg syndrome. Hum Mol Genet 1995;4:2131-2137
32. Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993;52:455-462
33. Zlotogora J, Lerer I, Bar-David S, Ergaz Z, Abeliovich D. Homozygosity for Waardenburg syndrome. Am J Hum Genet 1995;56:1173-1178
34. Asher JH Jr, Sommer A, Morell R, Friedman TB. Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. Hum Mutat 1996;7:30-35
35. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994;8:251-255
36. Hodgkinson CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993; 74:395-404
37. Hughes AE, Newton VE, Liu XZ, Read AP. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet 1994; 7:509-512
38. Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia A, et al. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002;100:1274-1286
39. Sanchez-Martin M, Rodriguez-Garcia A, Perez-Losada J, Sagrera A, Read AP, Sanchez-Garcia I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002;11:3231-3236
40. Hosoda K, Hammer RE, Richardson JA, et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994;79:1267-1276
41. Baynash AG, Hosoda K, Giaid A, et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994;79:1277-1285
42. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998;18:60-64
43. Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-1266
44. Attie T, Till M, Pelet A, et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995;4:2407-2409
45. Edery P, Attie T, Amiel J, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996;12:442-444
46. Hofstra RM, Osinga J, Tan-Sindhunata G, et al. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:445-447
47. Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;18:171-173
48. Pingault V, Bondurand N, Lemort N, et al. A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes? J Med Genet 2001;38:205-209
49. Tachibana M, Kobayashi Y, Matsushima Y. Mouse models for four types of Waardenburg syndrome. Pigment Cell Res 2003;16:448-454
50. Hibino H, Horio Y, Inanobe A, et al. An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci 1997;17:4711-4721
51. Yasumoto K, Yokoyama K, Shibata K, Tomita Y, Shibahara S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 1994;14:8058-8070
52. Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet 1998; 18:283-286
53. Bondurand N, Pingault V, Goerich DE, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 2000;9:1907-1917
54. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 1991;10:1135-1147
55. Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB. Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma. Genomics 2002;79:278-284
56. Pandya A, Xia XJ, Landa BL, et al. Phenotypic variation in Waardenburg syndrome: mutational heterogeneity, modifier genes or polygenic background? Hum Mol Genet 1996;5:497-502
57. Morell R, Spritz RA, Ho L, et al. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Hum Mol Genet 1997;6:659-664
58. Baldwin CT, Hoth CF, Macina RA, Milunsky A. Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am J Med Genet 1995;58:115-122
59. Morell R, Friedman TB, Asher JH Jr, Robbins LG. The incidence of deafness is non-randomly distributed among families segregating for Waardenburg syndrome type 1 (WS1). J Med Genet 1997; 34:447-452
60. DeStefano AL, Cupples LA, Arnos KS, et al. Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations. Hum Genet 1998;102:499-506
61. Asher JH Jr, Harrison RW, Morell R, Carey ML, Friedman TB. Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation. Genomics 1996;34:285-298
62. Schultz JM, Yang Y, Caride AJ, et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med 2005;352:1557-1564
63. Riazuddin S, Castelein CM, Ahmed ZM, et al. Dominant modifier DFNM1 suppresses recessive deafness DFNB26. Nat Genet 2000;26:431-434
64. Noben-Trauth K, Zheng QY, Johnson KR. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 2003;35:21-23
65. Ikeda A, Zheng QY, Zuberi AR, Johnson KR, Naggert JK, Nishina PM. Microtubule-associated protein 1A is a modifier of tubby hearing (moth1). Nat Genet 2002;30:401-405
66. Ng L, Rusch A, Amma LL, et al. Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the Thra thyroid hormone receptor alpha gene. Hum Mol Genet 2001;10:2701-2708
67. Kveton J, Balkany TJ. Status of cochlear implantation in children. American Academy of Otolaryngology-Head and Neck Surgery Subcommittee on Cochlear implants. J Pediatr 1991;118:1-7
68. Loundon N, Rouillon I, Munier N, Marlin S, Roger G, Garabedian EN. Cochlear implantation in children with internal ear malformations. Otol Neurotol 2005;26:668-673
69. Mylanus EA, Rotteveel LJ, Leeuw RL. Congenital malformation of the inner ear and pediatric cochlear implantation. Otol Neurotol 2004;25:308-317
70. Buchman CA, Copeland BJ, Yu KK, Brown CJ, Carrasco VN, Pillsbury HC III. Cochlear implantation in children with congenital inner ear malformations. Laryngoscope 2004;114:309-316